Moving from Policy to Action: Fighting the Nation’s Drug Overdose and Death Epidemic

In 2021, drug-related overdose deaths topped 107,000.1 Despite a nearly 50% decrease in opioid prescribing over the past decade, drug overdose mortality continues to trend in the opposite direction.2 In particular, drug-related deaths have disproportionately impacted Black, American Indian, Native Alaskan Americans and young people.

The staggering data drives home the need for evidence-based policy and leadership to reduce drug-related overdoses. The American Medical Association (AMA) and Manatt Health released a national policy roadmap in December 2020 with detailed recommendations for policymakers. In 2022, the AMA and Manatt launched a more comprehensive state toolkit that identified specific laws, regulations and other initiatives that demonstrated success. Now, in a new webinar, we highlight leading physicians, other health care professionals and advocates taking action across the six areas that were the focus of our reports:

  • Increasing access to evidence-based treatments to help patients with a substance use disorder (SUD)
  • Ensuring access to addiction medicine, psychiatry and other trained physicians
  • Improving access to multidisciplinary, multimodal care for patients with pain
  • Enforcing mental health and SUD parity laws
  • Expanding harm reduction efforts to reduce death and disease
  • Enhancing public health data surveillance, monitoring and evaluation


  • Joel Ario, Managing Director, Manatt Health
  • Daniel Blaney-Koen, Senior Legislative Attorney, AMA


  • Patrice A. Harris, MD, MA, former AMA President; Chair, AMA Substance Use and Pain Care Task Force
  • Bobby Mukkamala, MD, Immediate Past Chair, AMA Board of Trustees; Chair, AMA Substance Use and Pain Care Task Force

Date and Time:

Monday, December 12


2 IQVIA Xponent limited to retail pharmacy dispensed prescriptions.

If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at

This program does not constitute legal advice, nor does it establish an attorney-client relationship. Views expressed by presenters are strictly their own and should not be construed to be the views of Manatt or attributed to Manatt.



pursuant to New York DR 2-101(f)

© 2024 Manatt, Phelps & Phillips, LLP.

All rights reserved